June 21, 2018
Kemin debuts next-generation immune primer for animals in Asia
Since 2017, Kemin Industries has organised several seminars in various regions to introduce Aleta™.
The product is a pure and highly bioavailable immunomodulator which provides a high and consistent concentration of Beta 1,3 Glucan to improve immunity and animal performance.
In relation to AletaTM, Kemin continues to deliver seminars to existing and potential customers as a value-added service to ensure they are aware of how to achieve the best possible outcome in animal production.
Dr. Geoff Horst, Kemin's research and development lead, and inventor of AletaTM, was the principal speaker for a recent series of seminars in South Korea. The presentations were tailored so that each customer was introduced to the most-relevant new technologies and solutions, as well as recent trial results for AletaTM.
"Improving immunity is the key to improving farm productivity and mitigating disease outbreak," said Dr. Horst.
Dr. Horst also explained why the patented, algae-derived AletaTM is the next-generation immune primer.
The molecular structure of AletaTM is very distinct when compared with the conventional yeast-derived beta-glucan. In addition, AletaTM contains a higher purity of beta-glucan. Its particles are also much smaller in size, making the product unique and easily assimilated by the animal's immune system after absorption through the intestines.
Dr. Hans Lee, technical sales manager of Kemin Animal Nutrition and Health (Asia Pacific), expressed confidence that AletaTM will help farmers meet consumers' demands for safe and healthy food.